Blueprint Medicines Corp (NASDAQ:BPMC) — Stock Price
Blueprint Medicines Corp (NASDAQ:BPMC) is currently trading at $129.46 USD, up 0.00% today. Over the past 52 weeks, shares have ranged between $129.46 and $129.46. This page tracks Blueprint Medicines Corp's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BPMC company net worth.
Blueprint Medicines Corp (BPMC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Blueprint Medicines Corp's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Daily price history is not currently available for Blueprint Medicines Corp.
Blueprint Medicines Corp Income Statement — Revenue, Profit & Earnings by Year
Blueprint Medicines Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | $508.82 Million | $249.38 Million | $204.04 Million | $180.08 Million | $793.74 Million |
| Cost of Revenue | $20.16 Million | $12.80 Million | $17.81 Million | $17.93 Million | $425.00K |
| Gross Profit | $488.66 Million | $236.58 Million | $186.22 Million | $162.15 Million | $793.31 Million |
| Research & Development | $341.43 Million | $427.72 Million | $477.42 Million | $601.03 Million | $326.86 Million |
| SG&A | $262.67 Million | $278.24 Million | $219.27 Million | $181.79 Million | $148.34 Million |
| Total Operating Expenses | $700.71 Million | $722.86 Million | $723.74 Million | $804.13 Million | $484.60 Million |
| Operating Income | $-212.04 Million | $-486.28 Million | $-549.25 Million | $-648.46 Million | $302.15 Million |
| EBITDA | $19.23 Million | $-470.36 Million | $-515.41 Million | $-628.30 Million | $308.71 Million |
| EBIT | $2.94 Million | $-482.02 Million | $-535.51 Million | $-641.08 Million | $296.36 Million |
| Interest Expense | $68.81 Million | $51.60 Million | $16.77 Million | $7.38 Million | $12.79 Million |
| Income Before Tax | $-65.86 Million | $-506.02 Million | $-552.28 Million | $-641.08 Million | $314.94 Million |
| Income Tax Expense | $1.23 Million | $968.00K | $5.24 Million | $3.00 Million | $1.06 Million |
| Net Income | $-67.09 Million | $-506.98 Million | $-557.52 Million | $-644.09 Million | $313.88 Million |
Blueprint Medicines Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Blueprint Medicines Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $1.18 Billion | $1.05 Billion | $1.35 Billion | $1.25 Billion | $1.72 Billion |
| Total Current Assets | $742.68 Million | $808.39 Million | $1.05 Billion | $554.02 Million | $927.76 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | $513.47 Million | $639.36 Million | $825.28 Million | $267.17 Million | $187.21 Million |
| Net Receivables | $77.61 Million | $43.18 Million | $36.94 Million | $37.03 Million | $25.31 Million |
| Inventory | $13.61 Million | $21.22 Million | $29.70 Million | $21.82 Million | $8.58 Million |
| Property, Plant & Equipment | — | — | $33.34 Million | $30.70 Million | $34.13 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $881.15 Million | $918.64 Million | $835.23 Million | $281.49 Million | $248.31 Million |
| Total Current Liabilities | $260.80 Million | $214.92 Million | $183.23 Million | $149.76 Million | $130.80 Million |
| Long-term Debt | $343.05 Million | $208.53 Million | $535.28 Million | — | — |
| Net Debt | $298.30 Million | $702.84 Million | $122.74 Million | $-98.54 Million | $-595.03 Million |
| Total Stockholder Equity | $298.67 Million | $130.61 Million | $514.68 Million | $970.74 Million | $1.47 Billion |
| Retained Earnings | $-2.41 Billion | $-2.34 Billion | $-1.83 Billion | $-1.28 Billion | $-631.36 Million |
Blueprint Medicines Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Blueprint Medicines Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-192.59 Million | $-436.85 Million | $-502.28 Million | $-298.65 Million | $387.04 Million |
| Capital Expenditures | $4.63 Million | $16.06 Million | $8.92 Million | $261.24 Million | $3.16 Million |
| Free Cash Flow | $-197.22 Million | $-452.91 Million | $-511.20 Million | $-559.89 Million | $383.88 Million |
| Investing Cash Flow | $-47.50 Million | $274.04 Million | $-149.54 Million | $-225.86 Million | $-434.25 Million |
| Financing Cash Flow | $273.11 Million | $119.22 Million | $561.81 Million | $50.72 Million | $617.76 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $108.91 Million | $92.67 Million | $98.97 Million | $91.63 Million | $75.53 Million |
| Depreciation | $16.29 Million | $11.66 Million | $11.73 Million | $6.48 Million | $6.56 Million |
| Change in Cash | $32.12 Million | $-43.38 Million | $-90.22 Million | $-474.69 Million | $570.20 Million |
Blueprint Medicines Corp Earnings History — EPS Actual vs. Analyst Estimates
Track Blueprint Medicines Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 23, 2025 | 0.00 | -0.22 | +100.00% |
| Jul 30, 2025 | — | -0.44 | — |
| Apr 30, 2025 | -0.29 | -1.66 | +82.31% |
| Feb 13, 2025 | -0.79 | -0.71 | -10.63% |
| Oct 30, 2024 | -0.89 | -0.97 | +8.25% |
| Aug 01, 2024 | -0.80 | -1.29 | +37.98% |
| May 02, 2024 | 1.40 | -1.66 | +184.34% |
| Feb 15, 2024 | -1.82 | -2.04 | +10.78% |